RBL Bank share price jumped 3.28 percent on Friday. The private banking counter has been trading close to its yearly highs and technical charts suggest strong momentum in the stock.
News in Focus
In its latest research update, Mirae Asset Sharekhan maintains a BUY recommendation on Tata Consultancy Services (TCS), India’s IT bellwether, despite a challenging quarter marked by subdued revenu
Motilal Oswal has reiterated its BUY rating on Glenmark Pharmaceuticals, setting a compelling price target of Rs 2,430—implying a robust 28% upside from current levels.
Exness has stopped new memberships in India and there isn't any clarification from the company regarding this change.
Typography is one of the most crucial elements of poster design.
SBI Life Share price jumped 1.37 percent on Friday and the stock is currently looking bullish on technical charts. We could face minor resistance in range of Rs 1,860 - 1,875.
Main Regional Stories
Featured, Analyst View, Stock Markets, Crompton Greaves, Electronics Sector, India, Kotak Securities
Kotak Institutional Equities has issued a resounding BUY call on Crompton Greaves Consumer, setting a fair value target of Rs 410 against the current market price of Rs 344.
Featured, India Business, Stock Trading, Asahi India, Buzzing Stocks, Glenmark Pharmaceuticals, India, Ramco Cements
Ramco Cements, Asahi India Glass and Glenmark Pharmaceuticals shares were among major gainers on Friday. Glenmark Pharmaceuticals gained 20% during the trading session after AbbVie deal was announced.
Glenmark Pharmaceuticals has seized the spotlight within India’s pharmaceutical landscape, propelled by a record-breaking global licensing agreement for its flagship oncology asset.
